Search results
Results From The WOW.Com Content Network
Andrew David Huberman (born September 26, 1975) is an American neuroscientist and podcaster. He is an associate professor of neurobiology and ophthalmology at the Stanford University School of Medicine. Since 2021, he has hosted the popular health and science focused Huberman Lab podcast. The podcast has attracted criticism for promoting poorly ...
Good morning! Accenture CEO Julie Sweet shares cancer diagnosis, Brooke Rollins is confirmed as secretary of agriculture, and Fortune’s Ellie Austin dives into the boom in companies focused on ...
Another added: “This article shows Andrew Huberman to be a huge dirtbag and very dishonorable in his treatment of women, although its description of his management of a five-simultaneous ...
Flmodafinil (developmental code names CRL-40,940, NLS-4, JBG01-41), also known as bisfluoromodafinil and lauflumide, is a wakefulness-promoting agent related to modafinil which has been developed for treatment of a variety of different medical conditions.
Eugeroics, in the sense of modafinil-type wakefulness promoting agents, include modafinil itself, armodafinil, and adrafinil, among others. [9] They are medically indicated for the treatment of certain sleep disorders , including excessive daytime sleepiness (EDS) in narcolepsy or obstructive sleep apnea (OSA).
However, Andrew Huberman, a professor of neurobiology and ophthalmology at Stanford School of Medicine and host of The Huberman Lab, suggests we quiet the noise and return to the basics ...
The post The Huberman Problem: Integrity Counts, Always appeared first on AGEIST. Integrity matters. This was on my mind when I read the Andrew Huberman profile in NY Mag this week.
A Cephalon-founded study in which patients were administered modafinil, methylphenidate, and a placebo found that modafinil produces "psychoactive and euphoric effects and feelings consistent with [methylphenidate]." [12] Like modafinil, armodafinil is an inhibitor and/or inducer of certain cytochrome P450 enzymes.